| MolName | (2R)-2-[(5Z)-4-oxo-5-[(E)-3-phenylprop-2-enylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]-2-phenylacetate |
| MolecularFormula | C20H14NO3S2 |
| Smiles | [O-]C([C@@H](c1ccccc1)N(C(/C(/S1)=C/C=C/c2ccccc2)=O)C1=S)=O |
| InChI | InChI=1S/C20H15NO3S2/c22-18-16(13-7-10-14-8-3-1-4-9-14)26-20(25)21(18)17(19(23)24)15-11-5-2-6-12-15/h1-13,17H,(H,23,24)/p-1/t17-/m1/s1 |
| InChIK | KYPFHZXHBBGHQE-QGZVFWFLSA-M |
| TotalMolweight | 380.467 |
| Molweight | 380.467 |
| MonoisotopicMass | 380.041509 |
| CLogP | 0.4062 |
| CLogS | -4.319 |
| H Acceptors | 4 |
| TotalSurfaceArea | 286.76 |
| Relative PSA | 0.31176 |
| PolarSurfaceArea | 117.83 |
| Druglikeness | 4.1361 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | high |
| Nasty Functions | |
| Shape Index | 0.57692 |
| Fragments | 1 |
| Non HAtoms | 26 |
| NonCHAtoms | 6 |
| Electronegative Atoms | 6 |
| StereoCenters | 1 |
| Rotatable Bond | 5 |
| Rings Closures | 3 |
| Small Rings | 3 |
| Aromatic Rings | 2 |
| Aromatic Atoms | 12 |
| Sp3Atoms | 4 |
| Symmetricatoms | 4 |
| Amides | 1 |
| AcidicOxygens | 1 |
| StereoCon | this enantiomer |
Click to Load Molecule:
1 - (2R)-2-[(5Z)-4-oxo-5-[(E)-3-phenylprop-2-enylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]-2-phenylacetate | 2 - (2R)-2-[(5Z)-4-oxo-5-[(E)-3-phenylprop-2-enylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]-2-phenylacetate